Institutional Ownership Regeneron Pharmaceuticals, Inc. (REGN)
This table provides information about the institutional ownership of Regeneron Pharmaceuticals, Inc. (REGN). We have compiled data on the 1,418 institutions that hold shares in the stock, with a total of 88.7 Million shares, which have been reported (via 13F filing form) to have a value of $53.2 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
American Portfolios Advisors
Holbrook, NY |
Mar 17, 2023 Q3 2022 |
297
shares
|
$178,200
0.01% of portfolio
|
Q2 2020
Reduced 40.31%
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
288
shares
|
$172,800
0.0% of portfolio
|
Q2 2025
New holding
|
|
Independence Bank Of Kentucky
|
Jul 17, 2025 Q2 2025 |
286
shares
|
$171,600
0.02% of portfolio
|
Q2 2025
Added 23.81%
|
|
Manchester Capital Management LLC
Manchester, VT |
Aug 12, 2025 Q2 2025 |
284
shares
|
$170,400
0.02% of portfolio
|
Q2 2025
Added 27.35%
|
|
Syntax Advisors, LLC
New York, NY |
Nov 13, 2023 Q3 2023 |
282
shares
|
$169,200
0.4% of portfolio
|
Q3 2023
Reduced 8.14%
|
|
Onefund, LLC
Saint Petersburg, FL |
Aug 15, 2025 Q2 2025 |
274
shares
|
$164,400
0.1% of portfolio
|
Q2 2025
New holding
|
|
Rexford Capital Inc
Bellaire, TX |
Aug 15, 2025 Q2 2025 |
273
shares
|
$163,800
0.12% of portfolio
|
Q2 2025
New holding
|
|
Twin Lakes Capital Management, LLC
Redwood Shores, CA |
Jul 31, 2025 Q2 2025 |
267
shares
|
$160,200
0.09% of portfolio
|
Q2 2025
Added 0.38%
|
|
Amica Retiree Medical Trust
|
Aug 07, 2025 Q2 2025 |
264
shares
|
$158,400
0.2% of portfolio
|
Q1 2025
Reduced 19.27%
|
|
Wealthpoint, LLC
|
Oct 12, 2023 Q3 2023 |
263
shares
|
$157,800
0.09% of portfolio
|
Q3 2023
Reduced 12.62%
|
|
Euclidean Technologies Management, LLC
|
Apr 26, 2023 Q1 2023 |
263
shares
|
$157,800
0.2% of portfolio
|
Q1 2023
New holding
|
|
Kelly Lawrence W & Associates Inc
Pasadena, CA |
Aug 14, 2025 Q2 2025 |
263
shares
|
$157,800
0.04% of portfolio
|
Q4 2024
Added 10.5%
|
|
Fort, L.P.
Chevy Chase, MD |
Oct 29, 2024 Q3 2024 |
257
shares
|
$154,200
0.7% of portfolio
|
Q3 2024
Reduced 10.76%
|
|
Abbrea Capital, LLC
|
Aug 08, 2024 Q2 2024 |
253
shares
|
$151,800
0.04% of portfolio
|
Q2 2024
Reduced 5.6%
|
|
Lazard Asset Management LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
251
shares
|
$150,600
0.0% of portfolio
|
Q2 2025
Reduced 98.52%
|
|
Estabrook Capital Management
New York, NY |
Aug 13, 2025 Q2 2025 |
250
shares
|
$150,000
0.02% of portfolio
|
Q3 2023
Reduced 10.71%
|
|
Anchor Investment Management, LLC
Columbia, SC |
Aug 19, 2025 Q2 2025 |
250
shares
|
$150,000
0.01% of portfolio
|
Q2 2025
Reduced 79.1%
|
|
Solstein Capital, LLC
Menlo Park, CA |
Jul 31, 2025 Q2 2025 |
248
shares
|
$148,800
0.07% of portfolio
|
Q2 2025
Reduced 14.19%
|
|
Brown Brothers Harriman & CO
New York, NY |
Aug 11, 2025 Q2 2025 |
248
shares
|
$148,800
0.0% of portfolio
|
Q2 2025
Reduced 10.79%
|
|
Syntax Research, Inc.
Boca Raton, FL |
Jul 21, 2025 Q2 2025 |
245
shares
|
$147,000
0.09% of portfolio
|
Q3 2024
Reduced 28.99%
|
|
Hamilton Wealth, LLC
|
Nov 14, 2024 Q3 2024 |
240
shares
|
$144,000
0.07% of portfolio
|
Q2 2024
Reduced 47.94%
|
|
Capula Management LTD
Grand Cayman, E9 |
Aug 13, 2025 Q2 2025 |
240
shares
|
$144,000
0.0% of portfolio
|
Q2 2025
Added 25.65%
|
|
Creative Financial Designs Inc
|
Aug 04, 2025 Q2 2025 |
231
shares
|
$138,600
0.01% of portfolio
|
Q2 2025
Added 5.0%
|
|
Janiczek Wealth Management, LLC
|
Jul 25, 2024 Q2 2024 |
229
shares
|
$137,400
0.05% of portfolio
|
Q2 2024
Added 3.62%
|
|
Ronald Blue Trust, Inc.
Brentwood, TN |
Jul 24, 2025 Q2 2025 |
228
shares
|
$136,800
0.0% of portfolio
|
Q2 2025
Reduced 31.12%
|